NovoCure Limited
NVCR
$15.23
$0.030.20%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 60.99% | -107.28% | 62.84% | -21.92% | -20.27% |
| Total Depreciation and Amortization | 25.06% | 24.03% | 55.56% | 49.02% | 20.50% |
| Total Amortization of Deferred Charges | -- | -- | 0.19% | -- | -- |
| Total Other Non-Cash Items | -44.23% | 168.67% | -72.69% | 6.28% | 7.77% |
| Change in Net Operating Assets | 163.36% | 71.41% | -431.62% | 94.04% | -296.54% |
| Cash from Operations | 151.03% | 62.10% | -421.70% | 98.28% | -826.51% |
| Capital Expenditure | -26.07% | 51.45% | 45.25% | 47.07% | 52.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -98.70% | 211.65% | 2,671.57% | 269.28% | 111.42% |
| Cash from Investing | -117.72% | 219.70% | 1,614.23% | 600.83% | 109.61% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 90.53% | -92.57% | -40.52% | 438.00% | -27.84% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 90.53% | -103.16% | -20,937.77% | 100,417.00% | -97.27% |
| Foreign Exchange rate Adjustments | -103.02% | -157.27% | 40.63% | -125.29% | 444.16% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -72.28% | 83.45% | -944.14% | 827.47% | 107.86% |